Paralysis Versus Non‐Paralysis Anesthesia for Operative Laryngoscopy: A Randomized Controlled Trial
The Laryngoscope · 2023
DOI: 10.1002/lary.30571 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, 2023. Verfasst von Jackie Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Propofol, Neuromuscular Nondepolarizing Agents. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objective
To compare outcomes between two standard‐of‐care anesthesia regimens for operative laryngoscopy: general anesthesia with a neuromuscular blocking agent (NMBA) versus remifentanil and propofol (non‐NMBA).
Methods
This was a prospective, single‐blinded, randomized controlled trial at a tertiary care center. Patients were randomized to either anesthesia using rocuronium (NMBA) or with remifentanil/propofol infusion alone (non‐NMBA). Intraoperative impressions, anesthesia data, and post‐operative patient surveys were collected.
Results
Sixty‐one patients who underwent suspension laryngoscopy from 2020 to 2022 were included (25 female, 36 male, ranging 20–81 years). Thirty patients were enrolled in the NMBA arm and 31 patients in the non‐NMBA arm. Heart rate and mean arterial pressure were higher in the NMBA ( p < 0.01). Patients in the non‐NMBA group were more likely to require vasopressors ( p = 0.04, RR = 3.08 [0.86–11.05]). Surgeons were more frequently satisfied with conditions in the NMBA group (86.7%) compared to the non‐NMBA group (58.1%, p < 0.01). Procedures were more likely to be paused due to movement in the non‐NMBA group (45.1%) compared to the NMBA group (16.6%, p < 0.03, RR = 2.26 [1.02–4.99]). Patients in the non‐NMBA group were more likely to endorse myalgia the week after surgery (44%) compared to the NMBA group (8.3%, p < 0.01) and reported higher average pain levels on a 0–10 pain scale (3.7) compared to the paralysis group (2.0).
Conclusions
Anesthesia with rocuronium was associated with better intraoperative conditions and postoperative pain compared to anesthesia with remifentanil/propofol. Remifentanil/propofol were associated with lower blood pressure and suppression of laryngoscopy‐associated tachycardia. Level of Evidence 2 Laryngoscope , 133:2654–2664, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NYU Grossman School of Medicine, New York, New York, USA.
- Department of Otolaryngology-Head and Neck Surgery, NYU Langone, New York, New York, USA.
- Department of Anesthesiology, Perioperative Care & Pain Medicine, NYU Grossman School of Medicine, New York, New York, USA.
ORCID-Profile: Jackie Yang, Sophia Chen, Sachi Patil
Zitieren
APA
Yang, J., Crosby, T., Chen, S., Ezeh, U. C., Patil, S., Kwak, P. E., Chin, W. A., & Amin, M. R. (2023). Paralysis Versus Non‐Paralysis Anesthesia for Operative Laryngoscopy: A Randomized Controlled Trial. The Laryngoscope. https://doi.org/10.1002/lary.30571
Vancouver
Yang J, Crosby T, Chen S, Ezeh UC, Patil S, Kwak PE, et al. Paralysis Versus Non‐Paralysis Anesthesia for Operative Laryngoscopy: A Randomized Controlled Trial. The Laryngoscope. 2023. doi:10.1002/lary.30571
BibTeX
@article{Yang2023,
author = {Yang, Jackie and Crosby, Tyler and Chen, Sophia and Ezeh, Uche C and Patil, Sachi and Kwak, Paul E and Chin, Wanda A and Amin, Milan R},
title = {Paralysis Versus Non‐Paralysis Anesthesia for Operative Laryngoscopy: A Randomized Controlled Trial},
journal = {The Laryngoscope},
year = {2023},
doi = {10.1002/lary.30571}
}
EUVIMED